BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26069927)

  • 1. Design, synthesis and in vitro trypanocidal and leishmanicidal activities of novel semicarbazone derivatives.
    Alves MA; de Queiroz AC; Alexandre-Moreira MS; Varela J; Cerecetto H; González M; Doriguetto AC; Landre IM; Barreiro EJ; Lima LM
    Eur J Med Chem; 2015 Jul; 100():24-33. PubMed ID: 26069927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of quinazoline derivatives as anti-trypanosomatid and anti-plasmodial agents.
    Mendoza-Martínez C; Correa-Basurto J; Nieto-Meneses R; Márquez-Navarro A; Aguilar-Suárez R; Montero-Cortes MD; Nogueda-Torres B; Suárez-Contreras E; Galindo-Sevilla N; Rojas-Rojas Á; Rodriguez-Lezama A; Hernández-Luis F
    Eur J Med Chem; 2015; 96():296-307. PubMed ID: 25899334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, leishmanicidal, trypanocidal and cytotoxic activity of quinoline-hydrazone hybrids.
    Coa JC; Castrillón W; Cardona W; Carda M; Ospina V; Muñoz JA; Vélez ID; Robledo SM
    Eur J Med Chem; 2015 Aug; 101():746-53. PubMed ID: 26218652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of New Thiosemicarbazones and Semicarbazones Containing the 1,2,3-1H-triazole-isatin Scaffold: Trypanocidal, Cytotoxicity, Electrochemical Assays, and Molecular Docking.
    Silva BNM; Sales Junior PA; Romanha AJ; Murta SMF; Lima CHS; Albuquerque MG; D'Elia E; Rodrigues JGA; Ferreira VF; Silva FC; Pinto AC; Silva BV
    Med Chem; 2019; 15(3):240-256. PubMed ID: 30332972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicomponent reaction-based synthesis and biological evaluation of tricyclic heterofused quinolines with multi-trypanosomatid activity.
    Di Pietro O; Vicente-García E; Taylor MC; Berenguer D; Viayna E; Lanzoni A; Sola I; Sayago H; Riera C; Fisa R; Clos MV; Pérez B; Kelly JM; Lavilla R; Muñoz-Torrero D
    Eur J Med Chem; 2015 Nov; 105():120-37. PubMed ID: 26479031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Arylamino-6-nitroquinazolines: Synthesis and their activities against neglected disease leishmaniasis.
    Saad SM; Ghouri N; Perveen S; Khan KM; Choudhary MI
    Eur J Med Chem; 2016 Jan; 108():13-20. PubMed ID: 26619389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis.
    Cavalcanti de Queiroz A; Alves MA; Barreiro EJ; Lima LM; Alexandre-Moreira MS
    Exp Parasitol; 2019 Jun; 201():57-66. PubMed ID: 31004571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thio- and selenosemicarbazones as antiprotozoal agents against
    Ibáñez-Escribano A; Fonseca-Berzal C; Martínez-Montiel M; Álvarez-Márquez M; Gómez-Núñez M; Lacueva-Arnedo M; Espinosa-Buitrago T; Martín-Pérez T; Escario JA; Merino-Montiel P; Montiel-Smith S; Gómez-Barrio A; López Ó; Fernández-Bolaños JG
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):781-791. PubMed ID: 35193444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro leishmanicidal activity of 2-(1-methyl-5-nitro-1H-imidazol-2-yl)-5-substituted-1,3,4-thiadiazole derivatives.
    Foroumadi A; Emami S; Pournourmohammadi S; Kharazmi A; Shafiee A
    Eur J Med Chem; 2005 Dec; 40(12):1346-50. PubMed ID: 16095763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding the family of heteroleptic oxidovanadium(IV) compounds with salicylaldehyde semicarbazones and polypyridyl ligands showing anti-Trypanosoma cruzi activity.
    Scalese G; Benítez J; Rostán S; Correia I; Bradford L; Vieites M; Minini L; Merlino A; Coitiño EL; Birriel E; Varela J; Cerecetto H; González M; Pessoa JC; Gambino D
    J Inorg Biochem; 2015 Jun; 147():116-25. PubMed ID: 25824466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of novel 2,3-disubstituted quinoxaline derivatives as antileishmanial and antitrypanosomal agents.
    Cogo J; Kaplum V; Sangi DP; Ueda-Nakamura T; Corrêa AG; Nakamura CV
    Eur J Med Chem; 2015 Jan; 90():107-23. PubMed ID: 25461316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing and exploring active N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against three Trypanosoma cruzi strains more prevalent in Chagas disease patients.
    Palace-Berl F; Pasqualoto KF; Jorge SD; Zingales B; Zorzi RR; Silva MN; Ferreira AK; de Azevedo RA; Teixeira SF; Tavares LC
    Eur J Med Chem; 2015; 96():330-9. PubMed ID: 25899337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of Sulfonamide Derivatives in the Treatment of Trypanosomatid Parasites including Trypanosoma cruzi, Trypanosoma brucei, and Leishmania ssp.
    Scarim CB; Chelucci RC; Dos Santos JL; Chin CM
    Med Chem; 2020; 16(1):24-38. PubMed ID: 31218962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triclosan-caffeic acid hybrids: Synthesis, leishmanicidal, trypanocidal and cytotoxic activities.
    Otero E; García E; Palacios G; Yepes LM; Carda M; Agut R; Vélez ID; Cardona WI; Robledo SM
    Eur J Med Chem; 2017 Dec; 141():73-83. PubMed ID: 29028533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro evaluation of leishmanicidal and trypanocidal activities of N-quinolin-8-yl-arylsulfonamides.
    da Silva LE; Joussef AC; Pacheco LK; da Silva DG; Steindel M; Rebelo RA; Schmidt B
    Bioorg Med Chem; 2007 Dec; 15(24):7553-60. PubMed ID: 17889546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiprotozoal activities of marine polyether triterpenoids.
    Díaz-Marrero AR; López-Arencibia A; Bethencout-Estrella CJ; Cen-Pacheco F; Sifaoui I; Hernández Creus A; Duque-Ramírez MC; Souto ML; Hernández Daranas A; Lorenzo-Morales J; Piñero JE; Fernández JJ
    Bioorg Chem; 2019 Nov; 92():103276. PubMed ID: 31539745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of anti-Trypanosoma cruzi oxadiazoles leads to identification of compounds with efficacy in infected mice.
    dos Santos Filho JM; Moreira DR; de Simone CA; Ferreira RS; McKerrow JH; Meira CS; Guimarães ET; Soares MB
    Bioorg Med Chem; 2012 Nov; 20(21):6423-33. PubMed ID: 23006639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of a new series of 3,5-disubstituted isoxazoles active against Trypanosoma cruzi and Leishmania amazonensis.
    da Rosa R; de Moraes MH; Zimmermann LA; Schenkel EP; Steindel M; Bernardes LSC
    Eur J Med Chem; 2017 Mar; 128():25-35. PubMed ID: 28152426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of benzenesulfonyl derivatives as anti-Trypanosomatidae agents: Structural design, synthesis, and pharmacological assessment against Trypanosoma cruzi and Leishmania infantum.
    Freitas de Lima Hercos G; Gabriela Faleiro de Moura Lodi Cruz M; Clara Cassiano Martinho A; de Melo Resende D; Farago Nascimento D; Derksen Macruz P; Jorge Pilau E; Maria Fonseca Murta S; de Oliveira Rezende Júnior C
    Bioorg Med Chem; 2024 May; 105():117736. PubMed ID: 38677111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and identification of novel molecular hybrids based on naphthoquinone aromatic hydrazides as potential trypanocide and leishmanicidal agents.
    Cezar RD; Silva AOD; Lopes RS; Nakamura CV; Rodrigues JHS; Lourenço EMG; Saba S; Beatriz A; Rafique J; Lima DP
    An Acad Bras Cienc; 2024; 96(2):e20230375. PubMed ID: 38747836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.